Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2010-02-23 Annual Report
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Annual Report 2010
Annual Report
2010-02-23 Danish
Annual Report 2009
Annual Report Classification · 100% confidence The document is titled 'Annual report 2009' and contains comprehensive financial statements, including income statements, balance sheets, cash flow statements, and management reviews. It provides detailed financial highlights and key ratios for the fiscal year. Although it begins with a short company release announcement, the bulk of the provided text constitutes the actual annual report content, which fits the definition of a 10-K (Annual Report). FY 2009
2010-02-23 English
Report Publication Announcement 2010
Report Publication Announcement Classification · 99% confidence The document is titled 'Company release No 4/2010' and provides an 'Updated financial calendar for the 2010 financial year'. It lists future dates for the release of the Annual Report, the Annual General Meeting (AGM), and various interim reports (Q1, Q2, Q3). Since the document's primary function is to announce the schedule and timing of future corporate reports and events, rather than being the report itself, it fits the definition of a Report Publication Announcement (RPA). The document length is short (1342 chars), supporting the 'MENU VS MEAL' rule, as it is announcing reports rather than containing them.
2010-02-22 English
Regulatory Filings 2010
Regulatory Filings
2010-02-22 Danish
Regulatory Filings 2010
Regulatory Filings
2010-02-15 Danish
Regulatory Filings 2010
Regulatory Filings Classification · 85% confidence The document is a short company release (3174 characters) from ALK-Abelló A/S, dated February 15, 2010, announcing that a clinical trial for their product GRAZAX® met its primary endpoint. It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal dividend notice (DIV). It is a specific announcement regarding clinical trial results, which often falls under general regulatory news or investor relations updates. Since it is a specific, time-sensitive announcement about a clinical milestone, and not a general regulatory filing fallback (RNS), it best fits the category of an announcement related to the business or investor information. However, none of the provided categories perfectly capture a 'Clinical Trial Update'. Given the options, this is a specific business update that is not a formal financial report, management change, or shareholder action. It is most closely related to general company news disseminated via regulatory channels. Since it is a formal company release (Company release No 3/2010) announcing a significant business development, and it is not a formal financial report, the most appropriate general category for non-financial, non-management, non-shareholder specific regulatory news is RNS (Regulatory Filings), as it is a formal announcement to the exchange (NASDAQ OMX Copenhagen A/S). If a more specific 'Clinical Trial Update' existed, that would be preferred, but RNS serves as the best fit for this type of formal, non-financial regulatory disclosure.
2010-02-15 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.